Literature DB >> 16593622

Crystal and molecular structure of chymotrypsin inhibitor 2 from barley seeds in complex with subtilisin Novo.

C A McPhalen1, I Svendsen, I Jonassen, M N James.   

Abstract

The serine proteinase inhibitor from barley seeds, chymotrypsin inhibitor 2(CI-2), has been crystallized in a molecular complex with subtilisin Novo (EC 3.4.21.14). The crystal structure of this complex has been determined at 2.1-A resolution by the molecular replacement method and partially refined by restrained-parameter least-squares methods. The present crystallographic R factor (SigmaFo[unk] - [unk]Fc/Sigma[unk]Fo[unk]) is 0.193. CI-2 is a member of the potato inhibitor 1 family; it is a serine proteinase inhibitor lacking disulfide bonds. Comparison of the subtilisin molecule in this complex with the native subtilisin shows that the two molecules are very similar in structure. The inhibitor binds in a mode presumably resembling that of a true substrate, but it is not cleaved. This is in accord with the reported structures of other serine proteinase-inhibitor complexes. CI-2 consists of a four-stranded mixed parallel and antiparallel beta-sheet against which an alpha-helix packs to form a hydrophobic core. A wide loop crossover connection between parallel strands 2 and 3 of the beta-sheet contains the reactive-site bond. The conformation of the four residues to either side of the reactive-site bond is similar to that of the analogous residues in the third domain of the turkey ovomucoid inhibitor (Kazal family); the overall polypeptide chain fold of these inhibitors and the location of the reactive site in the respective chains are different.

Entities:  

Year:  1985        PMID: 16593622      PMCID: PMC390825          DOI: 10.1073/pnas.82.21.7242

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

2.  Subtilisin; a stereochemical mechanism involving transition-state stabilization.

Authors:  J D Robertus; J Kraut; R A Alden; J J Birktoft
Journal:  Biochemistry       Date:  1972-11-07       Impact factor: 3.162

3.  An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.

Authors:  J D Robertus; R A Alden; J J Birktoft; J Kraut; J C Powers; P E Wilcox
Journal:  Biochemistry       Date:  1972-06-20       Impact factor: 3.162

4.  Subtilisin Novo. The three-dimensional structure and its comparison with subtilisin BPN'.

Authors:  J Drenth; W G Hol; J N Jansonius; R Koekoek
Journal:  Eur J Biochem       Date:  1972-03-27

5.  Atomic coordinates for subtilisin BPN' (or Novo).

Authors:  R A Alden; J J Birktoft; J Kraut; J D Robertus; C S Wright
Journal:  Biochem Biophys Res Commun       Date:  1971-10-15       Impact factor: 3.575

6.  The structure of subtilisin Novo.

Authors:  S A Olaitan; R J DeLange; E L Smith
Journal:  J Biol Chem       Date:  1968-10-25       Impact factor: 5.157

7.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

8.  Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.

Authors:  C A McPhalen; H P Schnebli; M N James
Journal:  FEBS Lett       Date:  1985-08-19       Impact factor: 4.124

9.  The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3).

Authors:  W Bode; O Epp; R Huber; M Laskowski; W Ardelt
Journal:  Eur J Biochem       Date:  1985-03-01

10.  Chymotrypsin inhibitor I from potatoes. Large scale preparation and characterization of its subunit components.

Authors:  J C Melville; C A Ryan
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

View more
  20 in total

1.  Small-world communication of residues and significance for protein dynamics.

Authors:  Ali Rana Atilgan; Pelin Akan; Canan Baysal
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  Molecular basis for the resistance of an insect chymotrypsin to a potato type II proteinase inhibitor.

Authors:  K M Dunse; Q Kaas; R F Guarino; P A Barton; D J Craik; M A Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

3.  Long-range electrostatic complementarity governs substrate recognition by human chymotrypsin C, a key regulator of digestive enzyme activation.

Authors:  Jyotica Batra; András Szabó; Thomas R Caulfield; Alexei S Soares; Miklós Sahin-Tóth; Evette S Radisky
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Understanding specificity of the mycosin proteases in ESX/type VII secretion by structural and functional analysis.

Authors:  Jonathan M Wagner; Timothy J Evans; Jing Chen; Haining Zhu; Edith N G Houben; Wilbert Bitter; Konstantin V Korotkov
Journal:  J Struct Biol       Date:  2013-10-07       Impact factor: 2.867

5.  Evolution of the proteinase inhibitor I family and apparent lack of hypervariability in the proteinase contact loop.

Authors:  L L Beuning; T W Spriggs; J T Christeller
Journal:  J Mol Evol       Date:  1994-12       Impact factor: 2.395

Review 6.  Protonation and pK changes in protein-ligand binding.

Authors:  Alexey V Onufriev; Emil Alexov
Journal:  Q Rev Biophys       Date:  2013-05       Impact factor: 5.318

7.  Site-directed mutagenesis and the role of the oxyanion hole in subtilisin.

Authors:  P Bryan; M W Pantoliano; S G Quill; H Y Hsiao; T Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue.

Authors:  Y Harpaz; N Elmasry; A R Fersht; K Henrick
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Characterization of calcium-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin with vanadyl ions: electron paramagnetic resonance and electron nuclear double resonance spectroscopy.

Authors:  D Mustafi; Y Nakagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Sampling bottlenecks in de novo protein structure prediction.

Authors:  David E Kim; Ben Blum; Philip Bradley; David Baker
Journal:  J Mol Biol       Date:  2009-07-28       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.